Meta-Analysis
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2014; 20(40): 14986-14991
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14986
Figure 1
Figure 1 Identification of eligible studies.
Figure 2
Figure 2 Meta-analysis of overall survival. NRCT: High-quality non-randomized comparative trial; RCT: Randomized controlled trial.
Figure 3
Figure 3 Meta-analysis of overall survival of serosa-positive patients. NRCT: High-quality non-randomized comparative trial; RCT: Randomized controlled trial.
Figure 4
Figure 4 Meta-analysis of recurrence-free survival. NRCT: High-quality non-randomized comparative trial; RCT: Randomized controlled trial.
Figure 5
Figure 5 Meta-analysis of recurrence-free survival of serosa-positive patients. NRCT: High-quality non-randomized comparative trial; RCT: Randomized controlled trial.
Figure 6
Figure 6 Funnel plot depicting the distribution of hazard ratios (HRs) comparing overall survival. HR: Hazard ratio.